-
Je něco špatně v tomto záznamu ?
Archetypal Analysis of Injury in Kidney Transplant Biopsies Identifies Two Classes of Early AKI
PF. Halloran, GA. Böhmig, J. Bromberg, G. Einecke, FA. Eskandary, G. Gupta, M. Myslak, O. Viklicky, A. Perkowska-Ptasinska, KS. Madill-Thomsen, INTERCOMEX Investigators
Jazyk angličtina Země Švýcarsko
Typ dokumentu časopisecké články
NLK
Directory of Open Access Journals
od 2014
Free Medical Journals
od 2014
PubMed Central
od 2014
Europe PubMed Central
od 2014
Open Access Digital Library
od 2014-01-01
Open Access Digital Library
od 2014-01-01
ROAD: Directory of Open Access Scholarly Resources
od 2014
PubMed
35463013
DOI
10.3389/fmed.2022.817324
Knihovny.cz E-zdroje
- Publikační typ
- časopisecké články MeSH
All transplanted kidneys are subjected to some degree of injury as a result of the donation-implantation process and various post-transplant stresses such as rejection. Because transplants are frequently biopsied, they present an opportunity to explore the full spectrum of kidney response-to-wounding from all causes. Defining parenchymal damage in transplanted organs is important for clinical management because it determines function and survival. In this study, we classified the scenarios associated with parenchymal injury in genome-wide microarray results from 1,526 kidney transplant indication biopsies collected during the INTERCOMEX study. We defined injury groups by using archetypal analysis (AA) of scores for gene sets and classifiers previously identified in various injury states. Six groups and their characteristics were defined in this population: No injury, minor injury, two classes of acute kidney injury ("AKI," AKI1, and AKI2), chronic kidney disease (CKD), and CKD combined with AKI. We compared the two classes of AKI, namely, AKI1 and AKI2. AKI1 had a poor function and increased parenchymal dedifferentiation but minimal response-to-injury and inflammation, instead having increased expression of PARD3, a gene previously characterized as being related to epithelial polarity and adherens junctions. In contrast, AKI2 had a poor function and increased response-to-injury, significant inflammation, and increased macrophage activity. In random forest analysis, the most important predictors of function (estimated glomerular filtration rate) and graft loss were injury-based molecular scores, not rejection scores. AKI1 and AKI2 differed in 3-year graft survival, with better survival in the AKI2 group. Thus, injury archetype analysis of injury-induced gene expression shows new heterogeneity in kidney response-to-wounding, revealing AKI1, a class of early transplants with a poor function but minimal inflammation or response to injury, a deviant response characterized as PC3, and an increased risk of failure. Given the relationship between parenchymal injury and kidney survival, further characterization of the injury phenotypes in kidney transplants will be important for an improved understanding that could have implications for understanding native kidney diseases (ClinicalTrials.gov #NCT01299168).
Alberta Transplant Applied Genomics Centre Edmonton AB Canada
Department of Nephrology Hannover Medical School Hannover Germany
Department of Surgery University of Maryland Baltimore MD United States
Division of Nephrology Virginia Commonwealth University Richmond VA United States
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc22017409
- 003
- CZ-PrNML
- 005
- 20220720100221.0
- 007
- ta
- 008
- 220718s2022 sz f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.3389/fmed.2022.817324 $2 doi
- 035 __
- $a (PubMed)35463013
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a sz
- 100 1_
- $a Halloran, Philip F $u Alberta Transplant Applied Genomics Centre, Edmonton, AB, Canada $u Division of Nephrology and Transplant Immunology, Department of Medicine, University of Alberta, Edmonton, AB, Canada
- 245 10
- $a Archetypal Analysis of Injury in Kidney Transplant Biopsies Identifies Two Classes of Early AKI / $c PF. Halloran, GA. Böhmig, J. Bromberg, G. Einecke, FA. Eskandary, G. Gupta, M. Myslak, O. Viklicky, A. Perkowska-Ptasinska, KS. Madill-Thomsen, INTERCOMEX Investigators
- 520 9_
- $a All transplanted kidneys are subjected to some degree of injury as a result of the donation-implantation process and various post-transplant stresses such as rejection. Because transplants are frequently biopsied, they present an opportunity to explore the full spectrum of kidney response-to-wounding from all causes. Defining parenchymal damage in transplanted organs is important for clinical management because it determines function and survival. In this study, we classified the scenarios associated with parenchymal injury in genome-wide microarray results from 1,526 kidney transplant indication biopsies collected during the INTERCOMEX study. We defined injury groups by using archetypal analysis (AA) of scores for gene sets and classifiers previously identified in various injury states. Six groups and their characteristics were defined in this population: No injury, minor injury, two classes of acute kidney injury ("AKI," AKI1, and AKI2), chronic kidney disease (CKD), and CKD combined with AKI. We compared the two classes of AKI, namely, AKI1 and AKI2. AKI1 had a poor function and increased parenchymal dedifferentiation but minimal response-to-injury and inflammation, instead having increased expression of PARD3, a gene previously characterized as being related to epithelial polarity and adherens junctions. In contrast, AKI2 had a poor function and increased response-to-injury, significant inflammation, and increased macrophage activity. In random forest analysis, the most important predictors of function (estimated glomerular filtration rate) and graft loss were injury-based molecular scores, not rejection scores. AKI1 and AKI2 differed in 3-year graft survival, with better survival in the AKI2 group. Thus, injury archetype analysis of injury-induced gene expression shows new heterogeneity in kidney response-to-wounding, revealing AKI1, a class of early transplants with a poor function but minimal inflammation or response to injury, a deviant response characterized as PC3, and an increased risk of failure. Given the relationship between parenchymal injury and kidney survival, further characterization of the injury phenotypes in kidney transplants will be important for an improved understanding that could have implications for understanding native kidney diseases (ClinicalTrials.gov #NCT01299168).
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Böhmig, Georg A $u Division of Nephrology and Dialysis, Department of Medicine III, Medical University of Vienna, Vienna, Austria
- 700 1_
- $a Bromberg, Jonathan $u Department of Surgery, University of Maryland, Baltimore, MD, United States
- 700 1_
- $a Einecke, Gunilla $u Department of Nephrology, Hannover Medical School, Hannover, Germany
- 700 1_
- $a Eskandary, Farsad A $u Division of Nephrology and Dialysis, Department of Medicine III, Medical University of Vienna, Vienna, Austria
- 700 1_
- $a Gupta, Gaurav $u Division of Nephrology, Virginia Commonwealth University, Richmond, VA, United States
- 700 1_
- $a Myslak, Marek $u Department of Clinical Interventions, Department of Nephrology and Kidney Transplantation Samodzielny Publiczny Wojewódzki Szpital Zespolony (SPWSZ) Hospital, Pomeranian Medical University, Szczecin, Poland
- 700 1_
- $a Viklicky, Ondrej $u Department of Nephrology and Transplant Center, Institute for Clinical and Experimental Medicine, Prague, Czechia
- 700 1_
- $a Perkowska-Ptasinska, Agnieszka $u Department of Transplantation Medicine, Nephrology and Internal Diseases, Medical University of Warsaw, Warsaw, Poland
- 700 1_
- $a Madill-Thomsen, Katelynn S $u Alberta Transplant Applied Genomics Centre, Edmonton, AB, Canada
- 710 2_
- $a INTERCOMEX Investigators
- 773 0_
- $w MED00188756 $t Frontiers in medicine $x 2296-858X $g Roč. 9, č. - (2022), s. 817324
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/35463013 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y - $z 0
- 990 __
- $a 20220718 $b ABA008
- 991 __
- $a 20220720100217 $b ABA008
- 999 __
- $a ind $b bmc $g 1816578 $s 1168651
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2022 $b 9 $c - $d 817324 $e 20220407 $i 2296-858X $m Frontiers in medicine $n Front. med. $x MED00188756
- LZP __
- $a Pubmed-20220718